These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 21586626
1. Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes. Pollack BP, Sapkota B, Cartee TV. Clin Cancer Res; 2011 Jul 01; 17(13):4400-13. PubMed ID: 21586626 [Abstract] [Full Text] [Related]
2. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells]. Guo R, Zou P, Song YP, Ma J, Lu HZ, Cao YL, Tong YJ. Zhonghua Er Ke Za Zhi; 2003 Dec 01; 41(12):925-8. PubMed ID: 14723817 [Abstract] [Full Text] [Related]
3. [Inhibition effect of CIITA anti-sense cDNA on the expression of MHCII molecules of Hela cells]. Guo R, Zou P, Fan HH, Cui L, Cao YL, Zheng B, Gao L, Gao F, Lu HZ. Zhonghua Xue Ye Xue Za Zhi; 2003 Dec 01; 24(12):636-9. PubMed ID: 14761611 [Abstract] [Full Text] [Related]
4. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ. Invest Ophthalmol Vis Sci; 2004 Sep 01; 45(9):3185-95. PubMed ID: 15326139 [Abstract] [Full Text] [Related]
5. Prolonged MHC class II expression and CIITA transcription in human keratinocytes. Takagi A, Nishiyama C, Kanada S, Niwa Y, Fukuyama K, Ikeda S, Okumura K, Ogawa H. Biochem Biophys Res Commun; 2006 Aug 25; 347(2):388-93. PubMed ID: 16836979 [Abstract] [Full Text] [Related]
6. [Influence of cyclosporine A on the mRNA and protein expression of major histocompatibility complexes I and II: experiment with rabbits]. Li XD, Zou X. Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2564-6. PubMed ID: 18067835 [Abstract] [Full Text] [Related]
7. [The expression and significance of major histocompatibility complex II transactivator gene in five human malignant hematological cell lines]. You Y, Zou P, Guo R. Zhonghua Nei Ke Za Zhi; 2004 Apr 25; 43(4):288-91. PubMed ID: 15130416 [Abstract] [Full Text] [Related]
8. Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling. Chung YL, Pui NN. J Dermatol Sci; 2011 Dec 25; 64(3):163-73. PubMed ID: 21924869 [Abstract] [Full Text] [Related]
9. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B. Br J Dermatol; 2008 May 25; 158(5):930-40. PubMed ID: 18284388 [Abstract] [Full Text] [Related]
10. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells. Croce M, De Ambrosis A, Corrias MV, Pistoia V, Occhino M, Meazza R, Giron-Michel J, Azzarone B, Accolla RS, Ferrini S. Oncogene; 2003 Oct 30; 22(49):7848-57. PubMed ID: 14586411 [Abstract] [Full Text] [Related]
11. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. Lian RH, Kotwal GJ, Wellhausen SR, Hunt LA, Justus DE. J Immunol; 1996 Jul 15; 157(2):864-73. PubMed ID: 8752940 [Abstract] [Full Text] [Related]
12. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins. Broxmeyer HE, Cooper S, Hangoc G, Chang CH. Exp Hematol; 2006 Aug 15; 34(8):1078-84. PubMed ID: 16863914 [Abstract] [Full Text] [Related]
13. Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27. Feng XM, Liu N, Yang SG, Hu LY, Chen XL, Fang ZH, Ren Q, Lu SH, Liu B, Han ZC. Biochem Biophys Res Commun; 2008 Mar 14; 367(3):553-9. PubMed ID: 18178151 [Abstract] [Full Text] [Related]
14. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA. Han Y, Zhou ZH, Ransohoff RM. J Immunol; 1999 Aug 01; 163(3):1435-40. PubMed ID: 10415044 [Abstract] [Full Text] [Related]
15. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W, Tang LP, Dong Y, Benveniste EN. J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712 [Abstract] [Full Text] [Related]
16. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells. Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K. Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734 [Abstract] [Full Text] [Related]
17. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells. Meissner M, Whiteside TL, Kaufmann R, Seliger B. Arch Dermatol Res; 2009 Feb 25; 301(2):189-93. PubMed ID: 19104823 [Abstract] [Full Text] [Related]
18. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1. Usui Y, Okunuki Y, Hattori T, Takeuchi M, Kezuka T, Goto H, Usui M. Invest Ophthalmol Vis Sci; 2006 Oct 25; 47(10):4607-13. PubMed ID: 17003458 [Abstract] [Full Text] [Related]
19. 15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism. Willermain F, Dulku S, Gonzalez NS, Blero D, Driessens G, De Graef C, Caspers L, Bruyns C. Prostaglandins Other Lipid Mediat; 2006 Sep 25; 80(3-4):136-43. PubMed ID: 16939878 [Abstract] [Full Text] [Related]
20. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition. Berghuis D, de Hooge AS, Santos SJ, Horst D, Wiertz EJ, van Eggermond MC, van den Elsen PJ, Taminiau AH, Ottaviano L, Schaefer KL, Dirksen U, Hooijberg E, Mulder A, Melief CJ, Egeler RM, Schilham MW, Jordanova ES, Hogendoorn PC, Lankester AC. J Pathol; 2009 Jun 25; 218(2):222-31. PubMed ID: 19274709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]